A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Amgen Inc stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 47,318 shares of AMGN stock, worth $12.4 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
47,318
Previous 35,364 33.8%
Holding current value
$12.4 Million
Previous $11 Million 37.99%
% of portfolio
0.88%
Previous 0.9%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$309.38 - $337.38 $3.7 Million - $4.03 Million
11,954 Added 33.8%
47,318 $15.2 Million
Q2 2024

Jul 15, 2024

SELL
$262.75 - $319.31 $105,100 - $127,724
-400 Reduced 1.12%
35,364 $11 Million
Q1 2024

Apr 23, 2024

BUY
$268.87 - $324.56 $268,870 - $324,560
1,000 Added 2.88%
35,764 $10.2 Million
Q4 2023

Jan 31, 2024

BUY
$255.7 - $288.46 $145,237 - $163,845
568 Added 1.66%
34,764 $10 Million
Q3 2023

Oct 20, 2023

BUY
$218.65 - $271.46 $153,055 - $190,022
700 Added 2.09%
34,196 $9.19 Million
Q2 2023

Jul 06, 2023

SELL
$214.27 - $253.37 $728,518 - $861,458
-3,400 Reduced 9.22%
33,496 $7.44 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $1.75 Million - $1.97 Million
-7,800 Reduced 17.45%
36,896 $8.32 Million
Q2 2022

Aug 16, 2022

SELL
$230.71 - $256.74 $415,278 - $462,132
-1,800 Reduced 3.87%
44,696 $10.9 Million
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $556,864 - $637,280
-2,800 Reduced 5.68%
46,496 $10.5 Million
Q3 2021

Oct 28, 2021

SELL
$212.27 - $248.7 $233,497 - $273,570
-1,100 Reduced 2.18%
49,296 $10.5 Million
Q2 2021

Jul 13, 2021

BUY
$233.58 - $259.14 $747,456 - $829,248
3,200 Added 6.78%
50,396 $12.3 Million
Q1 2021

May 07, 2021

BUY
$221.91 - $258.6 $1.31 Million - $1.53 Million
5,900 Added 14.29%
47,196 $11.7 Million
Q4 2020

Mar 02, 2021

BUY
$216.38 - $257.67 $519,312 - $618,408
2,400 Added 6.17%
41,296 $9.5 Million
Q3 2020

Nov 09, 2020

SELL
$234.65 - $260.95 $93,860 - $104,380
-400 Reduced 1.02%
38,896 $9.89 Million
Q1 2020

Apr 22, 2020

BUY
$182.24 - $241.7 $309,808 - $410,890
1,700 Added 4.52%
39,296 $7.97 Million
Q4 2019

Jan 28, 2020

SELL
$189.21 - $243.2 $454,104 - $583,680
-2,400 Reduced 6.0%
37,596 $9.06 Million
Q2 2019

Jul 19, 2019

BUY
$166.7 - $195.41 $133,360 - $156,328
800 Added 2.04%
39,996 $7.37 Million
Q1 2019

May 09, 2019

BUY
$180.87 - $203.88 $90,435 - $101,940
500 Added 1.29%
39,196 $7.45 Million
Q3 2018

Oct 26, 2018

SELL
$185.29 - $208.89 $2.33 Million - $2.63 Million
-12,600 Reduced 24.56%
38,696 $8.02 Million
Q2 2018

Jul 10, 2018

BUY
$166.05 - $186.51 $132,840 - $149,208
800 Added 1.58%
51,296 $9.47 Million
Q1 2018

Apr 11, 2018

SELL
$169.43 - $198.0 $1.39 Million - $1.62 Million
-8,200 Reduced 13.97%
50,496 $3.54 Million
Q4 2017

Jan 18, 2018

SELL
$168.79 - $188.59 $607,644 - $678,924
-3,600 Reduced 5.78%
58,696 $10.2 Million
Q3 2017

Oct 12, 2017

BUY
$167.29 - $191.0 $10.4 Million - $11.9 Million
62,296
62,296 $11.6 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Livforsakringsbolaget Skandia, Omsesidigt Portfolio

Follow Livforsakringsbolaget Skandia, Omsesidigt and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

News

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.